INTRODUCTION
The incidence of papillary thyroid carcinoma (PTC) is increasing worldwide, rising 2.9-fold between 1988 and 2002 in the United States [1] . It is now the most prevalent cancer in Korean women [2] .
With the rising incidence of PTC, there is a need for new safe surgical techniques that require less operating time so that more patients can be treated in a timely manner.
Although the extent of thyroidectomy remains controversial, total thyroidectomy (TT) has been one of the most frequently performed operations for patients with PTC. Complete resection of the thyroid gland results in fewer loco-regional recurrences and facilitates detection of metastatic disease, both by serum thyroglobulin (Tg) evaluation and by postablation 131 I whole body scan [3, 4] .
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However, TT has more postoperative complications, such as permanent recurrent laryngeal nerve (RLN) palsy and hypoparathyroidism, than unilateral lobectomy [5] . Since development of the harmonic scalpel (HS) in the early 1990s, it has been used in thyroid surgery to ensure a dry surgical field and to satisfy the surgeon's need for surgical efficiency. The synchronous action of the HS for simultaneous cutting and coagulation of blood vessels is beneficial in reducing operating time, compared with conventional suture ligation techniques or other vessel sealing devices [6] [7] [8] [9] . In addition, the capability of the HS to seal vessels and assure coagulation at low temperatures (between 50°C and 100°C) results in less thermal damage to surrounding structures [10] . Previous studies have confirmed a reduction in postoperative complications after thyroidectomy with HS [11, 12] .
The HS was initially used in open thyroid surgery for treatment of benign or malignant thyroid disease [7] .
Subsequently, it was shown to be advantageous in minimally invasive endoscopic thyroidectomy [13, 14] . To date, a number of HS studies in thyroid surgery have been 
METHODS

Patient selection
We We excluded patients who underwent less than TT, completion thyroidectomy, lateral neck node dissection, endoscopic thyroidectomy, or robotic-assisted endoscopic thyroidectomy.
In all, a total of 212 PTC patients were selected who met the following four inclusion criteria:
1) The TT was performed in our hospital. According to ATA guidelines [15] , TT is recommended in the following circumstances: 1) primary thyroid cancer ＞1 cm; 2) presence of contralateral thyroid nodules or regional or distant metastases; 3) history of radiation therapy to the head and neck; 4) patient has a first-degree relative with differentiated thyroid cancer; 5) age ＞45 years; 6) presence of extracapsular invasion or multifocality.
Of the 212 patients with PTC enrolled in this study, 104 were in the HS group and 108 in the CT group. All had prophylactic ipsilateral central compartment node dissection (CCND). In order to reduce interoperator confounding factors, all operations were performed by the same principal surgeon. The study was approved by the hospital's Institutional Review Board.
Preparation and
131
I ablation treatment
After surgery, all patients began treatment with a TSH-suppressing dose of LT4 (2 μg/kg). In the present study, radioactive iodine (RI) was given therapeutically 
TSH and Tg assay
Stimulated serum Tg, serum TgAb, and serum TSH were measured at ablation. Serum TSH was measured by chemiluminescence immunoassay (Centaur; Bayer Health Care, Mannheim, Germany). Serum Tg was measured by immunoradiometric assay (Dynotest TgS, Brahms, Berlin, Germany), and, similarly, for TgAbs (Anti-Tgn RIA, Brahms). The Tg assay had a sensitivity of 0.2 ng/mL. TgAb status was considered negative when readings were ＜20 IU/mL.
Surgical technique
TT is defined as total bilateral extracapsular thyro- Values are presented as mean ± SD or number (%). PTC, papillary thyroid carcinoma; HS, harmonic scalpel; CT, conventional total thyroidectomy; TNM, tumor-node-metastasis; LN, lymph nodes. Laryngoscopy was performed preoperatively for evaluation of vocal cord mobility in all patients. Gauze pieces were weighed before and after use for estimation of the amount of intraoperative bleeding (1 g, 1 mL of blood).
Outcome assessment
Postoperative calcium, phosphorus, and parathyroid hormone (PTH) levels were monitored in all patients.
Hypocalcemia was defined as a serum calcium level 
Statistical analysis
All data were expressed as mean ± standard deviation, proportions, or absolute numbers. We used SPSS ver. 13.0 (SPSS Inc., Chicago, IL, USA) for statistical analysis.
Statistical differences between the two groups were assessed by the Student's t-test or the Mann-Whitney test for continuous variables, depending on distribution. Interarm comparisons of categorical variables were performed using the chi-square test. P ＜ 0.05 was accepted as a significant difference.
RESULTS
Clinicopathological findings of both groups are shown in Table 1 . The groups were well matched for age and sex (P-value, not significant). There were no differences in Values are presented as mean ± SD or number (%). CT group, with significant between-group differences (P = 0.001). Mean serum Tg levels after TSH stimulation were 1.57 ± 3.17 ng/mL for the HS group and 3.95 ± 10.14 ng/mL for the CT group, with significant between-group differences (P = 0.028). There was no significant difference in serum TgAbs levels between the groups.
DISCUSSION
Surgeons who treat PTC have always been concerned with surgical and oncologic safety. Surgical safety can be defined as the best way to reduce perioperative morbidity in surgical patients. Oncologic safety can be defined as the best way to improve treatment outcome in cancer patients.
Until now, most reports of use of the HS in thyroid surgery have emphasized its utility in terms of time saving and perioperative morbidity without demonstrating its oncologic safety in relation to surgical completeness. Our study included only PTC patients who underwent TT so that we could evaluate how effective the HS was in completely removing the diseased thyroid gland.
Our results show the HS was a faster surgical technique than CT, saving 36 minutes on average, consistent with most studies [6] [7] [8] [9] 11] . The shorter operating time implies the possibility for treatment of more patients in the same operative sessions. Ultimately, HS could enable significant reduction of patients awaiting surgery in Yonsei University Health System. Unlike other studies, we did not find statistically less intraoperative bleeding in the HS group [11, 17, 18] . Possibly the CT group had too little intraoperative bleeding for detection of a meaningful difference between the groups.
Our effort to consistently maintain a dry operative field through meticulous hemostasis in the CT group could also have made the operation easier and resulted in our favorable data.
In this study, the amount of postoperative drainage was thesurgery.or.kr less in the HS group than in the CT group, similar to prior reports [7, 12] . The explanation is that the HS achieves efficient hemostasis and minimal tissue manipulation during surgery. The reduction in postoperative drainage after HS surgery resulted in 1-day shorter hospital stays for the HS group and related cost savings. All patients in the study were admitted to the hospital the day before surgery and were not discharged until drains were removed.
Despite our positive findings for the use of HS in thyroid surgery, the technique has drawbacks. Mallur et al. [19] reported that with prolonged activation the HS generates considerable residual heat that can lead to unintended burning of adjacent tissue and skin. In addition, to avoid permanent complications, a safety margin of 3 to 5 mm is required between the active curved blade and the RLN and parathyroid glands [20] . It is recommended that the inactive blade be the nearest tip to the nerve during cutting and coagulation. In our study, we found no statistical difference in complication rates between the two groups. Of particular importance, there were no cases with permanent RLN palsy or permanent hypoparathyroidism. We attribute this result to our use of HS in thyroid surgery only after initial training and overcoming the learning curve of a surgeon's adaption.
Although the extent of thyroidectomy in PTC patients is still under debate, Mazzaferri [4] reported that TT was the best operation in terms of oncologic safety. Most PTC patients have TT followed by 131 I ablation of the thyroid remnant, resulting in fewer recurrences, improved survival, and easier follow-up. Nevertheless, the current opinion is that, despite surgeons' best efforts, TT is rarely achievable. Microscopic or macroscopic thyroid remnants almost always remain and 131 I treatment is usually necessary for ablation of the remnants [21] .
In the present study, we found that at 131 I ablation, patients in the HS group had higher serum TSH levels and lower serum Tg levels than patients in the CT group. I ablation treatment with 30 mCi (1100 MBq), the protocol used in our hospital, usually destroys the thyroid remnant, providing that it is ＜2 to 3 g [4] . Therefore, the HS provided PTC patients with surgical completeness in that the optimal treatment goal is to eliminate all malignant thyroid tissue.
We questioned why patients in the HS group showed higher serum TSH levels and lower serum Tg levels at The present study had several limitations. The sample size was relatively small, and our study included only the short-term follow-up outcome because our goal was primarily to evaluate the surgical completeness of the HS technique. The short-term follow-up data for evaluating the effect by HS make assertions about surgical completeness and oncologic safety unclear. Therefore, large-scale randomized trials and long-term follow-up data are required to confirm our findings before definitive conclusions can be made.
In conclusion, TT using the HS is a relatively safe and efficient technique for use in PTC patients. In addition, the HS provides surgical completeness and a beneficial effect on successful ablation.
